cmn-vib.bsky.social
@cmn-vib.bsky.social
Another local one in our #CMNconsortia series:

We're part of µNEURO, a UAntwerp Research Centre of Excellence uniting neuropathology, genomics, and quantitative multimodal imaging to uncover pathogenic mechanisms in neurodevelopmental and neurodegenerative disorders.

https://tinyurl.com/24vhk8v6
November 13, 2025 at 1:17 PM
New paper alert! 🚨

The Jordanova lab contributed to a major international study uncovering the genetic cause of a childhood-onset, motor-predominant neuropathy.

The team identified one of the 20 families as part of this multicenter collaboration.

📄 https://www.jci.org/articles/view/184474
October 24, 2025 at 7:17 AM
One of the newest consortia we are part of is TRANSGEN.

In this consortium, CMN PIs team up colleagues from the UZA-UAntwerp Center of Medical Genetics to advance the translation of genomic and epigenomic insights into novel biomarkers and innovative therapies.

#CMNcohorts #CMNconsortia
October 23, 2025 at 2:14 PM
Today, the 2nd European CMT Specialist Conference kicks off, right here in Antwerp! 🎉
The Jordanova lab is well represented with Ayşe Candayan is giving a talk and Akram Khanghahi and Alexandra Ekshteyn are presenting posters
www.uantwerpen.be/en/conferences/2nd-european-cmt-specialist-conference/
October 23, 2025 at 11:34 AM
Sustainability is a team sport. 🙌

Credits to Sam Sluijs for coordinating the effort here at CMN.
Read more about our approach in this wonderful interview with Sam (pictures by Elisabeth Verwaest).
https://beakon.ghost.io/you-are-not-truly-working-safely-unless-you-are-also-working-sustainably/
October 21, 2025 at 10:42 AM
Spotlight on Solve-RD: a consortium solving the unsolved in rare diseases 👇

Sarah Weckhuysen and Vincent Timmerman contribute to Solve-RD, a pan-European effort uniting ERNs, clinicians, patient groups, and -omics experts to crack undiagnosed rare diseases.

#CMNcohorts #CMNconsortia
October 16, 2025 at 12:32 PM
We kicked off day 2 of #NHND25 with a session on neuro-inflammation in neurodegeneration, featuring Xiaoying Chen, Katerina Akassoglou, and our very own @seppedeschepper.bsky.social.
October 10, 2025 at 9:38 AM
Morning recap from #NHND25, where Albena Jordanova co-chaired the first session on better, human-relevant models for neurodegeneration, and Renzo Mancuso presented new data on how progranulin dosage shapes microglial trajectories.

Off to a great start!
@vibtrainconf.bsky.social
October 9, 2025 at 12:51 PM
The European Alzheimer & Dementia Biobank (EADB) unites cohorts across 18 countries to decode the genetics of Alzheimer’s disease. https://eadb.eu/
At CMN, the @sleegerslab.bsky.social plays a leading role, with postdoc Fahri Küçükali as our in-house EADB specialist.

#CMNcohorts #CMNconsortia
October 9, 2025 at 11:47 AM
Happy anniversary to the 1,000 Healthy Elderly Study! 🎂
On this day last year, we included our very first participant (again). Today we’re at 196 re-inclusions, and on track to hit 200 by the end of the week. 💪
A special thank you today to our study nurse, Sofie Van de kerckhoven! 🥳
#CMNcohorts
October 7, 2025 at 11:22 AM
Did you know that caring for someone with FTD can be one of the most demanding caregiving roles?

During this World FTD Awareness Week, we acknowledge the burden carers carry. For us, patients and their families are true partners in research.

#endFTD #WorldFTDAwarenessWeek
September 26, 2025 at 12:52 PM
Next up in our #CMNcohorts #CMNconsortia series, we spotlight a collaboration between the @sleegerslab.bsky.social and Dietmar Thal at KU Leuven: a post-mortem brain cohort, now paired with genetic characterization, and transcriptomic profiling underway.
September 25, 2025 at 3:31 PM
“What if it’s FTD?”

World FTD Awareness Week kicked off right after World Alzheimer’s Day on Sunday, a timely reminder that while FTD is the second most common dementia, it’s not Alzheimer’s.

#endFTD
September 24, 2025 at 3:47 PM
On #WorldAlzheimersDay, we’re reminded that progress is possible, and it’s powered by people. Every dataset, every partnership, every volunteer brings us closer to earlier detection and better treatments.

Thank you to our participants and collaborators. Hope moves forward together. 💜
September 21, 2025 at 10:18 AM
When the gene is mapped, the work is far from done.

In this interview with Julie van der Zee, we talk why long-horizon science only delivers if relationships, records, and ethics are cared for as diligently as the data.

https://blog.vib.be/from-first-families-to-first-trials
September 17, 2025 at 9:43 AM
The Rademakers lab presents the most comprehensive analysis of DNA methylation patterns in FTLD-TDP to date, revealing that the molecular differences between disease subtypes run even deeper than previously recognized.

https://tinyurl.com/4cahyuup
September 16, 2025 at 8:32 AM
That’s a wrap on the 2025 BioHackathon!

From 8 to 10 Sept, three hubs, at the University of Cambridge, VIB-University of Antwerp Center for Neurology, and Newcastle University, coded in sync on bioinformatics, math & computational biology.

See you at the next edition!
September 12, 2025 at 6:12 AM
We’re hiring a part-time (Junior) Linux System Administrator 📣

Join a small, collaborative IT team and support cutting-edge neuroscience research.

https://cmn.sites.vib.be/en/join-us#/job-description/122451
September 9, 2025 at 3:07 PM
Huge congratulations to Sebastiaan De Schepper on obtaining a prestigious ERC grant to launch PRIME-PD, a project uncovering how the immune system helps initiate and drive Parkinson’s disease. 🙌
September 4, 2025 at 12:14 PM
We’ve built our strategy around consortia-driven science, where our own expertise plugs into global networks, and local patient data fuels international discovery. From genetics to biomarkers, there’s power in numbers.
https://beakon.ghost.io/united-in-purpose/

#CMNcohorts #CMNconsortia
September 4, 2025 at 8:17 AM
Congratulations to Laura Morant from the @jordanovalab.bsky.social‪ on obtaining an AFM-Telethon Trampoline grant! 🎉

With the funding, she will explore the role of YARS1 in peripheral neuropathy and reconstruct its interaction with actin.
September 3, 2025 at 8:41 PM
We're counting down the weeks until #NHND25. @vibtrainconf.bsky.social

Seppe De Schepper is looking forward to Katerina Akassoglou’s talk, whose "work on perivascular neuroimmunology is fascinating. It beautifully connects vascular changes to immune signaling and neurodegeneration.”
September 2, 2025 at 2:42 PM
As translational timelines are tightening and evidence demands keep rising, we’ve made biobanking a strategic priority. Read how we are building a biobank that’s shareable by default, analysis-ready by design, and fast to collaborate with.
https://beakon.ghost.io/more-samples-less-friction/
August 29, 2025 at 2:11 PM
“It's good to have worked in more than one place—you pick up good habits from each lab.”
Read Trend's interview with our director Rosa Rademakers https://tinyurl.com/wnf4nytv
August 25, 2025 at 3:42 PM
Next up in our cohorts-and-consortia series:

ERDERA – European Rare Diseases Research Alliance 🧬

🧠 Rare disorders

🥼 New treatments and diagnostics

🌍 Over 180 leading organizations from 40 countries

📌 Sarah Weckhuysen's team at CMN
August 21, 2025 at 8:47 AM